From: Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases
FM Group
RD Group
p
x-ray pneumonia Na (%)
18 (23.1)
28 (50.0)
0.001
Admission to the hospital Na (%)
11 (14.1)
21 (37.5)
0.002
Number of symptoms mean (SD)b
5.33 (2.14)
4.18 (2.09)